Rocket Pharmaceuticals
RCKT
#5221
Rank
HK$9.22 B
Marketcap
HK$86.75
Share price
-5.51%
Change (1 day)
-61.96%
Change (1 year)

Revenue for Rocket Pharmaceuticals (RCKT)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Rocket Pharmaceuticals from 2014 to 2024

201620192022$0M0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA